UNRESECTABLE STAGE IV UROTHELIAL CANCER
Clinical trials for UNRESECTABLE STAGE IV UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE STAGE IV UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE STAGE IV UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bladder cancer patients who Can't take chemo?
Disease control OngoingThis Phase 2 trial is testing whether combining two drugs, durvalumab (an immunotherapy) and olaparib (a targeted therapy), can help people with advanced bladder cancer who are not healthy enough for standard platinum chemotherapy. About 154 participants will receive either the d…
Matched conditions: UNRESECTABLE STAGE IV UROTHELIAL CANCER
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Immunotherapy duo takes on advanced bladder cancer in global trial
Disease control OngoingThis study tested whether two immunotherapy drugs (durvalumab and tremelimumab) work better than standard chemotherapy for people with advanced bladder cancer that has spread (stage IV). Over 1,100 participants received either the drug combination, durvalumab alone, or chemo. The…
Matched conditions: UNRESECTABLE STAGE IV UROTHELIAL CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC